TY - JOUR
T1 - Effect of Vascular Access Strategy on Long-Term Outcomes in Patients with Out-of-hospital Cardiac Arrest A Randomised Clinical Trial
AU - Vallentin, Mikael Fink
AU - Holmberg, Mathias J
AU - Granfeldt, Asger
AU - Klitgaard, Thomas Lass
AU - Mikkelsen, Søren
AU - Folke, Fredrik
AU - Christensen, Helle Collatz
AU - Povlsen, Amalie Ling
AU - Petersen, Alberthe Hjort
AU - Winther, Sofie
AU - Frilund, Lea Wildt
AU - Meilandt, Carsten
AU - Winther, Kristian Blumensaadt
AU - Bach, Allan
AU - Dissing, Thomas H
AU - Terkelsen, Christian Juhl
AU - Christensen, Steffen
AU - Rasmussen, Line Kirkegaard
AU - Mortensen, Lone Riis
AU - Elkmann, Thomas
AU - Nielsen, Anders Gunnar
AU - Runge, Charlotte
AU - Klæstrup, Elise
AU - Holm, Jimmy Højberg
AU - Bak, Mikkel
AU - Nielsen, Lars-Gustav Rahbek
AU - Pedersen, Mette
AU - Kjærgaard-Andersen, Gunhild
AU - Hansen, Peter Martin
AU - Brøchner, Anne Craveiro
AU - Christensen, Erika Frischknecht
AU - Nielsen, Frederik Mølgaard
AU - Nissen, Christian Gade
AU - Bjørn, Jeppe Waldstrøm
AU - Burholt, Peter
AU - Obling, Laust E R
AU - Duus Holle, Sarah Louise
AU - Russell, Lene
AU - Alstrøm, Henrik
AU - Hestad, Søren
AU - Hove Buciek, Jens Ulrik
AU - Jakobsen, Karina
AU - Krag, Mette
AU - Sandgaard, Michael
AU - Sindberg, Birthe
AU - Andersen, Lars W
N1 - Copyright © 2026 The Author(s). Published by Elsevier B.V. All rights reserved.
PY - 2026
Y1 - 2026
N2 - OBJECTIVE: The Intravenous versus Intraosseous Vascular Access for Out-of-Hospital Cardiac Arrest (IVIO) trial was a randomised clinical trial that investigated initial vascular access strategy for out-of-hospital cardiac arrest. The current manuscript presents outcomes at 6 months and 1 year.METHODS: Adults with non-traumatic out-of-hospital cardiac arrest, in whom vascular access was indicated, were randomised to initial intraosseous or intravenous access. The allocated method was attempted up to two times. Prespecified 6-months and 1-year outcomes included survival, survival with a favourable neurological outcome, defined as a modified Rankin Scale score of 0-3, and health-related quality-of-life assessed using the EuroQoL 5-Dimension 5-Level questionnaire on domains of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.RESULTS: Of the 1479 patients included in the main manuscript primary analyses, three were lost to follow-up for 1-year survival. At 1 year, 82 patients (11%) in the intraosseous group and 68 patients (9%) in the intravenous group were alive (risk ratio 1.24; 95% confidence interval 0.91-1.67). Survival with a favourable neurological outcome was observed in 76 patients (10%) and 61 patients (8%), respectively (risk ratio 1.28; 95% confidence interval 0.93-1.77). Among survivors, the mean EQ-5D-5L numeric score was 83 in the intraosseous group and 76 in the intravenous group (mean difference 7; 95% confidence interval 1-13).CONCLUSION: Long-term outcomes were similar between patients who received initial intraosseous versus intravenous vascular access during adult out-of-hospital cardiac arrest. These findings do not support a difference in patient outcomes between the two vascular access strategies.TRIAL REGISTRATION: EU Clinical Trials number 2022-500744-38-00; ClinicalTrials.gov number NCT05205031.
AB - OBJECTIVE: The Intravenous versus Intraosseous Vascular Access for Out-of-Hospital Cardiac Arrest (IVIO) trial was a randomised clinical trial that investigated initial vascular access strategy for out-of-hospital cardiac arrest. The current manuscript presents outcomes at 6 months and 1 year.METHODS: Adults with non-traumatic out-of-hospital cardiac arrest, in whom vascular access was indicated, were randomised to initial intraosseous or intravenous access. The allocated method was attempted up to two times. Prespecified 6-months and 1-year outcomes included survival, survival with a favourable neurological outcome, defined as a modified Rankin Scale score of 0-3, and health-related quality-of-life assessed using the EuroQoL 5-Dimension 5-Level questionnaire on domains of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.RESULTS: Of the 1479 patients included in the main manuscript primary analyses, three were lost to follow-up for 1-year survival. At 1 year, 82 patients (11%) in the intraosseous group and 68 patients (9%) in the intravenous group were alive (risk ratio 1.24; 95% confidence interval 0.91-1.67). Survival with a favourable neurological outcome was observed in 76 patients (10%) and 61 patients (8%), respectively (risk ratio 1.28; 95% confidence interval 0.93-1.77). Among survivors, the mean EQ-5D-5L numeric score was 83 in the intraosseous group and 76 in the intravenous group (mean difference 7; 95% confidence interval 1-13).CONCLUSION: Long-term outcomes were similar between patients who received initial intraosseous versus intravenous vascular access during adult out-of-hospital cardiac arrest. These findings do not support a difference in patient outcomes between the two vascular access strategies.TRIAL REGISTRATION: EU Clinical Trials number 2022-500744-38-00; ClinicalTrials.gov number NCT05205031.
KW - Advanced life support
KW - Cardiac arrest
KW - Clinical trial
KW - Vascular access
UR - https://www.scopus.com/pages/publications/105036713353
U2 - 10.1016/j.resuscitation.2026.111087
DO - 10.1016/j.resuscitation.2026.111087
M3 - Journal article
C2 - 41967754
SN - 0300-9572
VL - 223
JO - Resuscitation
JF - Resuscitation
M1 - 111087
ER -